Skip to content

Public FDA record

Z-1221-03: BD Blood Glucose Test strips. BD Latitude, 100 Test Strips 100 Bandelettes Reactives, Manufactured for B

Recall record Z-1221-03 for Becton Dickinson & Company. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1221-03
Company in FDA record
Becton Dickinson & Company
FDA classification date
Sep 11, 2003
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Test Strips may not be meeting specifications at the lower range of glucose values.

Source facts

Action
On July 23, Becton Dickinson Canada sent out a recall notification to their Canadian customers to recall the product and return to BD Canada.
Initiated
2003-07-23
Root cause
Other
Terminated
2004-12-02
Distribution
Product was distributed to the Becton Dickinson Canada, Inc.,
Recall number
Z-1221-03
Recall status
Terminated
CDRH record ID
28784
FDA classified
2003-09-11
Recall event number
26927

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗